股本结构
单位：万股
| 公告日期 | 2025-11-05 | 2025-11-05 | 2025-08-06 | 2025-08-06 | 2025-05-08 | 2025-05-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 13912.50 | 13902.26 | 13891.64 | 13888.63 | 13823.80 | 13806.37 |
| 普通股本 | 13912.50 | 13902.26 | 13891.64 | 13888.63 | 13823.80 | 13806.37 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-10-29 | 2025-09-30 | 2025-07-30 | 2025-06-30 | 2025-04-30 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-05 | 13912.50 | 未披露 | 定期报告 | 2025-10-29 |
| 2025-11-05 | 13902.26 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Vesting of restricted common stock
Exercise of stock options
|
2025-09-30 |
| 2025-08-06 | 13891.64 | 未披露 | 定期报告 | 2025-07-30 |
| 2025-08-06 | 13888.63 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
|
2025-06-30 |
| 2025-05-08 | 13823.80 | 未披露 | 定期报告 | 2025-04-30 |
| 2025-05-08 | 13806.37 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Vesting of restricted common stock
Exercise of stock options
|
2025-03-31 |
| 2025-02-27 | 13714.33 | 未披露 | 定期报告 | 2025-02-20 |
| 2025-02-27 | 13695.94 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
|
2024-12-31 |
| 2024-11-04 | 13772.01 | 未披露 | 定期报告 | 2024-10-25 |
| 2024-11-04 | 13670.64 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Vesting of restricted common stock
Exercise of stock options
|
2024-09-30 |
| 2024-08-01 | 13663.96 | 未披露 | 定期报告 | 2024-07-26 |
| 2024-08-01 | 13659.01 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock under employee stock purchase plan
Exercise of stock options
Vesting of restricted common stock
|
2024-06-30 |
| 2024-05-03 | 13605.87 | 未披露 | 定期报告 | 2024-04-26 |
| 2024-04-19 | 13584.40 | 未披露 | 定期报告 | 2024-04-01 |
| 2024-05-03 | 13584.36 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Vesting of restricted common stock
Exercise of stock options
|
2024-03-31 |
| 2024-02-26 | 13503.23 | 未披露 | 定期报告 | 2024-02-16 |
| 2024-02-26 | 13478.13 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of stock options
Vesting of restricted common stock
Issuance of common stock under employee stock purchase plan
|
2023-12-31 |
| 2023-11-03 | 13452.13 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-11-03 | 13449.79 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of restricted common stock
|
2023-09-30 |
| 2023-08-04 | 13425.13 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-08-04 | 13423.05 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Issuance of common stock under employee stock purchase plan
Vesting of restricted common stock
|
2023-06-30 |
| 2023-05-08 | 13397.65 | 未披露 | 定期报告 | 2023-05-01 |
| 2023-05-08 | 13393.10 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Vesting of restricted common stock
Exercise of stock options
|
2023-03-31 |
| 2023-04-07 | 13393.09 | 未披露 | 定期报告 | 2023-03-30 |
| 2023-02-28 | 13353.14 | 未披露 | 定期报告 | 2023-02-21 |
| 2023-02-28 | 13323.67 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock under employee stock purchase plan
Issuance of common stock in connection with a grant agreement
Vesting of restricted common stock
Exercise of stock options
|
2022-12-31 |
| 2022-11-03 | 13311.56 | 未披露 | 定期报告 | 2022-10-31 |
| 2022-11-03 | 13302.74 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of stock options
Vesting of restricted common stock
|
2022-09-30 |
| 2022-08-09 | 13263.79 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-08-09 | 13259.78 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
|
2022-06-30 |
| 2022-05-05 | 13237.57 | 未披露 | 定期报告 | 2022-05-02 |
| 2022-05-05 | 13235.34 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock in connection with a grant agreement
Vesting of restricted common stock
Exercise of stock options
|
2022-03-31 |
| 2022-04-07 | 13234.16 | 未披露 | 定期报告 | 2022-03-28 |
| 2022-02-28 | 13230.36 | 未披露 | 定期报告 | 2022-02-22 |
| 2022-02-28 | 13116.14 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock to settle a contingent consideration
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
|
2021-12-31 |
| 2021-11-04 | 13088.02 | 未披露 | 定期报告 | 2021-11-01 |
| 2021-11-04 | 13082.61 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock to settle a contingent consideration
Vesting of restricted common stock
Exercise of stock options
|
2021-09-30 |
| 2021-08-05 | 13061.18 | 未披露 | 定期报告 | 2021-08-02 |
| 2021-08-05 | 13048.00 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Vesting of restricted common stock
Exercise of stock options
|
2021-06-30 |
| 2021-05-06 | 13003.98 | 未披露 | 定期报告 | 2021-05-03 |
| 2021-05-06 | 12989.19 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock in connection with a collaboration agreement
Vesting of restricted common stock
Exercise of stock options
|
2021-03-31 |
| 2021-04-06 | 12798.49 | 未披露 | 定期报告 | 2021-03-22 |
| 2021-02-25 | 12783.68 | 未披露 | 定期报告 | 2021-02-22 |
| 2021-02-25 | 12741.67 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with the achievement of a milestone
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock for cashless exercise of warrants
Issuance of common stock in connection with a follow-on offering, net of issuance costs of $21,786
Vesting of restricted common stock
Exercise of stock options
|
2020-12-31 |
| 2020-11-10 | 12738.86 | 未披露 | 定期报告 | 2020-11-06 |
| 2020-11-10 | 12699.16 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock in connection with a follow-on offering, net of issuance costs of $21,786
Vesting of restricted common stock
Exercise of stock options
|
2020-09-30 |
| 2020-08-11 | 12705.45 | 未披露 | 定期报告 | 2020-08-07 |
| 2020-07-10 | 12344.21 | 未披露 |
更多>>
1.Common stock to be offered by the company 7,142,857 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 116,299,280 shares of common stock (excluding 1,457,432 shares of unvested restricted common stock) outstanding as of March 31, 2020 on a pro forma basis.
|
2020-07-10 |
| 2020-08-11 | 11772.71 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock in connection with the achievement of a milestone
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock for cashless exercise of warrant
Vesting of restricted common stock
Exercise of stock options
|
2020-06-30 |
| 2020-05-12 | 11790.18 | 未披露 | 定期报告 | 2020-05-08 |
| 2020-05-12 | 10835.04 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Vesting of restricted common stock
Exercise of stock options
|
2020-03-31 |
| 2020-04-06 | 10980.35 | 未披露 | 定期报告 | 2020-03-27 |
| 2020-03-26 | 10979.96 | 未披露 | 定期报告 | 2020-03-23 |
| 2020-03-26 | 10764.89 | 未披露 |
更多>>
From December 31, 2018 to December 31, 2019
Issuance of Series B convertible preferred stock, net of issuance costs of $165
Conversion of convertible preferred stock into common stock
Issuance of common stock in connection with initial public offering, net of offering costs of $16,446
Issuance of common stock in connection with a license agreement
Repayment of promissory notes, net of unvested shares
Vesting of restricted common stock
Exercise of stock options
|
2019-12-31 |
| 2019-11-19 | 10967.88 | 未披露 | 定期报告 | 2019-11-15 |
| 2019-10-11 | 10939.72 | 未披露 |
更多>>
1.Common stock to be offered by us 7,142,858 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 102,254,338 shares of common stock (including (i) 88,112,733 shares issuable upon the conversion of all outstanding shares of our convertible preferred stock and (ii) 4,418,767 shares of unvested restricted common stock) outstanding as of June 30, 2019
|
2019-10-11 |
| 2019-11-19 | 1172.82 | 8811.27 |
更多>>
from June 30, 2019 to September 30, 2019
Issuance of common stock in connection with a license agreement
Repayment of promissory notes, net of unvested common stock
Vesting of restricted common stock
Exercise of stock options
|
2019-09-30 |
From June 30, 2025 to September 30, 2025
Vesting of restricted common stock
Exercise of stock options
From March 31, 2025 to June 30, 2025
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
From December 31, 2024 to March 31, 2025
Vesting of restricted common stock
Exercise of stock options
From December 31, 2023 to December 31, 2024
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
From June 30, 2024 to September 30, 2024
Vesting of restricted common stock
Exercise of stock options
From March 31, 2024 to June 30, 2024
Issuance of common stock under employee stock purchase plan
Exercise of stock options
Vesting of restricted common stock
From December 31, 2023 to March 31, 2024
Vesting of restricted common stock
Exercise of stock options
From December 31, 2022 to December 31, 2023
Exercise of stock options
Vesting of restricted common stock
Issuance of common stock under employee stock purchase plan
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of restricted common stock
From March 31, 2023 to June 30, 2023
Exercise of stock options
Issuance of common stock under employee stock purchase plan
Vesting of restricted common stock
From December 31, 2022 to March 31, 2023
Vesting of restricted common stock
Exercise of stock options
From December 31, 2021 to December 31, 2022
Issuance of common stock under employee stock purchase plan
Issuance of common stock in connection with a grant agreement
Vesting of restricted common stock
Exercise of stock options
From June 30, 2022 to September 30, 2022
Exercise of stock options
Vesting of restricted common stock
From March 31, 2022 to June 30, 2022
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
From December 31, 2021 to March 31, 2022
Issuance of common stock in connection with a grant agreement
Vesting of restricted common stock
Exercise of stock options
From December 31, 2020 to December 31, 2021
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock to settle a contingent consideration
Vesting of restricted common stock
Exercise of stock options
Issuance of common stock under employee stock purchase plan
From June 30, 2021 to September 30, 2021
Issuance of common stock to settle a contingent consideration
Vesting of restricted common stock
Exercise of stock options
From March 31, 2021 to June 30, 2021
Vesting of restricted common stock
Exercise of stock options
From December 31, 2020 to March 31, 2021
Issuance of common stock in connection with a collaboration agreement
Vesting of restricted common stock
Exercise of stock options
From December 31, 2019 to December 31, 2020
Issuance of common stock in connection with the achievement of a milestone
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock for cashless exercise of warrants
Issuance of common stock in connection with a follow-on offering, net of issuance costs of $21,786
Vesting of restricted common stock
Exercise of stock options
From June 30, 2020 to September 30, 2020
Issuance of common stock in connection with a follow-on offering, net of issuance costs of $21,786
Vesting of restricted common stock
Exercise of stock options
1.Common stock to be offered by the company 7,142,857 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 116,299,280 shares of common stock (excluding 1,457,432 shares of unvested restricted common stock) outstanding as of March 31, 2020 on a pro forma basis.
From March 31, 2020 to June 30, 2020
Issuance of common stock in connection with the achievement of a milestone
Issuance of common stock in connection with a collaboration agreement
Issuance of common stock for cashless exercise of warrant
Vesting of restricted common stock
Exercise of stock options
From December 31, 2019 to March 31, 2020
Vesting of restricted common stock
Exercise of stock options
From December 31, 2018 to December 31, 2019
Issuance of Series B convertible preferred stock, net of issuance costs of $165
Conversion of convertible preferred stock into common stock
Issuance of common stock in connection with initial public offering, net of offering costs of $16,446
Issuance of common stock in connection with a license agreement
Repayment of promissory notes, net of unvested shares
Vesting of restricted common stock
Exercise of stock options
1.Common stock to be offered by us 7,142,858 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 102,254,338 shares of common stock (including (i) 88,112,733 shares issuable upon the conversion of all outstanding shares of our convertible preferred stock and (ii) 4,418,767 shares of unvested restricted common stock) outstanding as of June 30, 2019
from June 30, 2019 to September 30, 2019
Issuance of common stock in connection with a license agreement
Repayment of promissory notes, net of unvested common stock
Vesting of restricted common stock
Exercise of stock options